ID	Description	GeneRatio	BgRatio	pvalue	p.adjust	qvalue	geneID	Count
R-HSA-1442490	Collagen degradation	7/37	64/10704	1.74362363272849e-09	4.32418660916666e-07	2.88156747724604e-07	COL1A2/COL3A1/COL4A1/COL4A2/COL6A2/CTSB/CTSD	7
R-HSA-877300	Interferon gamma signaling	7/37	91/10704	2.12556719418164e-08	2.63570332078523e-06	1.75638973413957e-06	B2M/HLA-A/HLA-B/HLA-C/HLA-DRA/HLA-DRB1/IFI30	7
R-HSA-1236977	Endosomal/Vacuolar pathway	4/37	11/10704	3.91845425350537e-08	3.23925551623111e-06	2.1585870800012e-06	B2M/HLA-A/HLA-B/HLA-C	4
R-HSA-2022090	Assembly of collagen fibrils and other multimeric structures	6/37	61/10704	5.39622292417521e-08	3.34565821298863e-06	2.22949210288292e-06	COL1A2/COL3A1/COL4A1/COL4A2/COL6A2/CTSB	6
R-HSA-2173782	Binding and Uptake of Ligands by Scavenger Receptors	5/37	42/10704	2.88997338618111e-07	1.3988327169397e-05	9.32159323257776e-06	COL1A2/COL3A1/COL4A1/COL4A2/JCHAIN	5
R-HSA-8948216	Collagen chain trimerization	5/37	44/10704	3.67111957967231e-07	1.3988327169397e-05	9.32159323257776e-06	COL1A2/COL3A1/COL4A1/COL4A2/COL6A2	5
R-HSA-1474228	Degradation of the extracellular matrix	7/37	140/10704	4.17901220391288e-07	1.3988327169397e-05	9.32159323257776e-06	COL1A2/COL3A1/COL4A1/COL4A2/COL6A2/CTSB/CTSD	7
R-HSA-3000480	Scavenging by Class A Receptors	4/37	19/10704	4.51236360303127e-07	1.3988327169397e-05	9.32159323257776e-06	COL1A2/COL3A1/COL4A1/COL4A2	4
R-HSA-1474290	Collagen formation	6/37	90/10704	5.62904413389074e-07	1.55111438356101e-05	1.03363734388403e-05	COL1A2/COL3A1/COL4A1/COL4A2/COL6A2/CTSB	6
R-HSA-983170	Antigen Presentation: Folding, assembly and peptide loading of class I MHC	4/37	25/10704	1.45103083475956e-06	3.37219060760744e-05	2.24717285821039e-05	B2M/HLA-A/HLA-B/HLA-C	4
R-HSA-186797	Signaling by PDGF	5/37	58/10704	1.49572970498717e-06	3.37219060760744e-05	2.24717285821039e-05	COL3A1/COL4A1/COL4A2/COL6A2/PLAT	5
R-HSA-1650814	Collagen biosynthesis and modifying enzymes	5/37	67/10704	3.08247919497863e-06	6.37045700295583e-05	4.24516871589162e-05	COL1A2/COL3A1/COL4A1/COL4A2/COL6A2	5
R-HSA-2132295	MHC class II antigen presentation	6/37	123/10704	3.53835780272288e-06	6.7500979621175e-05	4.49815526338051e-05	CD74/CTSB/CTSD/HLA-DRA/HLA-DRB1/IFI30	6
R-HSA-913531	Interferon Signaling	7/37	199/10704	4.43200396852957e-06	7.8509784585381e-05	5.23176408315145e-05	B2M/HLA-A/HLA-B/HLA-C/HLA-DRA/HLA-DRB1/IFI30	7
R-HSA-198933	Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell	6/37	132/10704	5.33064976781182e-06	8.81334094944888e-05	5.87306676172952e-05	B2M/COL1A2/COL3A1/HLA-A/HLA-B/HLA-C	6
R-HSA-3000178	ECM proteoglycans	5/37	76/10704	5.76568267803104e-06	8.93680815094811e-05	5.95534329243996e-05	COL1A2/COL3A1/COL4A1/COL4A2/COL6A2	5
R-HSA-216083	Integrin cell surface interactions	5/37	85/10704	1.00093256741493e-05	0.000146018398069943	9.73042805474576e-05	COL1A2/COL3A1/COL4A1/COL4A2/COL6A2	5
R-HSA-419037	NCAM1 interactions	4/37	42/10704	1.23114184171758e-05	0.000155497391387155	0.000103620927197722	COL3A1/COL4A1/COL4A2/COL6A2	4
R-HSA-156902	Peptide chain elongation	5/37	89/10704	1.25401122086415e-05	0.000155497391387155	0.000103620927197722	RPLP1/RPLP2/RPS17/RPS18/RPS6	5
R-HSA-192823	Viral mRNA Translation	5/37	89/10704	1.25401122086415e-05	0.000155497391387155	0.000103620927197722	RPLP1/RPLP2/RPS17/RPS18/RPS6	5
R-HSA-156842	Eukaryotic Translation Elongation	5/37	93/10704	1.55453031606392e-05	0.000167618921036458	0.00011169851698949	RPLP1/RPLP2/RPS17/RPS18/RPS6	5
R-HSA-2408557	Selenocysteine synthesis	5/37	93/10704	1.55453031606392e-05	0.000167618921036458	0.00011169851698949	RPLP1/RPLP2/RPS17/RPS18/RPS6	5
R-HSA-72764	Eukaryotic Translation Termination	5/37	93/10704	1.55453031606392e-05	0.000167618921036458	0.00011169851698949	RPLP1/RPLP2/RPS17/RPS18/RPS6	5
R-HSA-2214320	Anchoring fibril formation	3/37	15/10704	1.68127688228935e-05	0.00017106492995397	0.000113994881166271	COL1A2/COL4A1/COL4A2	3
R-HSA-975956	Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)	5/37	95/10704	1.72444485840696e-05	0.00017106492995397	0.000113994881166271	RPLP1/RPLP2/RPS17/RPS18/RPS6	5
R-HSA-72689	Formation of a pool of free 40S subunits	5/37	101/10704	2.32238108032026e-05	0.00021331500293312	0.000142149641173599	RPLP1/RPLP2/RPS17/RPS18/RPS6	5
R-HSA-9633012	Response of EIF2AK4 (GCN2) to amino acid deficiency	5/37	101/10704	2.32238108032026e-05	0.00021331500293312	0.000142149641173599	RPLP1/RPLP2/RPS17/RPS18/RPS6	5
R-HSA-2243919	Crosslinking of collagen fibrils	3/37	18/10704	2.99373281983917e-05	0.000265159192614326	0.000176697764178477	COL1A2/COL4A1/COL4A2	3
R-HSA-156827	L13a-mediated translational silencing of Ceruloplasmin expression	5/37	111/10704	3.66508634752565e-05	0.000306142740476485	0.000204008532490696	RPLP1/RPLP2/RPS17/RPS18/RPS6	5
R-HSA-1799339	SRP-dependent cotranslational protein targeting to membrane	5/37	112/10704	3.82678425595606e-05	0.000306142740476485	0.000204008532490696	RPLP1/RPLP2/RPS17/RPS18/RPS6	5
R-HSA-72706	GTP hydrolysis and joining of the 60S ribosomal subunit	5/37	112/10704	3.82678425595606e-05	0.000306142740476485	0.000204008532490696	RPLP1/RPLP2/RPS17/RPS18/RPS6	5
R-HSA-927802	Nonsense-Mediated Decay (NMD)	5/37	115/10704	4.34528958960864e-05	0.000326555096431195	0.000217610993801772	RPLP1/RPLP2/RPS17/RPS18/RPS6	5
R-HSA-975957	Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)	5/37	115/10704	4.34528958960864e-05	0.000326555096431195	0.000217610993801772	RPLP1/RPLP2/RPS17/RPS18/RPS6	5
R-HSA-3000171	Non-integrin membrane-ECM interactions	4/37	59/10704	4.80040088830286e-05	0.000343146230050289	0.000228667054829777	COL1A2/COL3A1/COL4A1/COL4A2	4
R-HSA-2408522	Selenoamino acid metabolism	5/37	118/10704	4.91667682076872e-05	0.000343146230050289	0.000228667054829777	RPLP1/RPLP2/RPS17/RPS18/RPS6	5
R-HSA-72613	Eukaryotic Translation Initiation	5/37	119/10704	5.11952036768577e-05	0.000343146230050289	0.000228667054829777	RPLP1/RPLP2/RPS17/RPS18/RPS6	5
R-HSA-72737	Cap-dependent Translation Initiation	5/37	119/10704	5.11952036768577e-05	0.000343146230050289	0.000228667054829777	RPLP1/RPLP2/RPS17/RPS18/RPS6	5
R-HSA-375165	NCAM signaling for neurite out-growth	4/37	63/10704	6.22104322704808e-05	0.000406004926396822	0.000270555065553061	COL3A1/COL4A1/COL4A2/COL6A2	4
R-HSA-1474244	Extracellular matrix organization	7/37	301/10704	6.46369132836748e-05	0.000411024474214137	0.000273900010405855	COL1A2/COL3A1/COL4A1/COL4A2/COL6A2/CTSB/CTSD	7
R-HSA-168273	Influenza Viral RNA Transcription and Replication	5/37	135/10704	9.33774001549879e-05	0.000578939880960925	0.000385796100640345	RPLP1/RPLP2/RPS17/RPS18/RPS6	5
R-HSA-1236974	ER-Phagosome pathway	4/37	83/10704	0.000182684255620445	0.00108698712032254	0.000724350500384715	B2M/HLA-A/HLA-B/HLA-C	4
R-HSA-168255	Influenza Infection	5/37	156/10704	0.000184434832080109	0.00108698712032254	0.000724350500384715	RPLP1/RPLP2/RPS17/RPS18/RPS6	5
R-HSA-6798695	Neutrophil degranulation	8/37	480/10704	0.000188469541023666	0.00108698712032254	0.000724350500384715	B2M/CTSB/CTSD/HLA-A/HLA-B/HLA-C/LYZ/PIGR	8
R-HSA-9010553	Regulation of expression of SLITs and ROBOs	5/37	171/10704	0.000282761406286486	0.00159374610816019	0.00106204643031049	RPLP1/RPLP2/RPS17/RPS18/RPS6	5
R-HSA-6803157	Antimicrobial peptides	4/37	95/10704	0.000307265292103678	0.00169337316537138	0.00112843627743339	DEFA5/LYZ/REG3A/REG3G	4
R-HSA-1236975	Antigen processing-Cross presentation	4/37	98/10704	0.000346077995344423	0.00186581180098733	0.00124334657366303	B2M/HLA-A/HLA-B/HLA-C	4
R-HSA-6791226	Major pathway of rRNA processing in the nucleolus and cytosol	5/37	184/10704	0.000396510773813287	0.0020922270618233	0.00139422601318446	RPLP1/RPLP2/RPS17/RPS18/RPS6	5
R-HSA-2172127	DAP12 interactions	3/37	45/10704	0.000488199508650478	0.00252236412802747	0.00168086234337994	B2M/HLA-B/HLA-C	3
R-HSA-8868773	rRNA processing in the nucleus and cytosol	5/37	194/10704	0.000505318988632459	0.00255016843544871	0.00169939068066829	RPLP1/RPLP2/RPS17/RPS18/RPS6	5
R-HSA-164940	Nef mediated downregulation of MHC class I complex cell surface expression	2/37	10/10704	0.000514146861985628	0.00255016843544871	0.00169939068066829	B2M/HLA-A	2
R-HSA-72312	rRNA processing	5/37	204/10704	0.000635297303772326	0.00308928884971641	0.00205865173771425	RPLP1/RPLP2/RPS17/RPS18/RPS6	5
R-HSA-72695	Formation of the ternary complex, and subsequently, the 43S complex	3/37	51/10704	0.000706329487487435	0.00336864832494007	0.00224481233877586	RPS17/RPS18/RPS6	3
R-HSA-376176	Signaling by ROBO receptors	5/37	218/10704	0.000857655974255151	0.00401318267198637	0.00267431952250365	RPLP1/RPLP2/RPS17/RPS18/RPS6	5
R-HSA-72649	Translation initiation complex formation	3/37	58/10704	0.00102929893878987	0.00464120248763433	0.00309282169167483	RPS17/RPS18/RPS6	3
R-HSA-72702	Ribosomal scanning and start codon recognition	3/37	58/10704	0.00102929893878987	0.00464120248763433	0.00309282169167483	RPS17/RPS18/RPS6	3
R-HSA-72662	Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S	3/37	59/10704	0.00108186831003488	0.00479113108729734	0.00319273166683227	RPS17/RPS18/RPS6	3
R-HSA-909733	Interferon alpha/beta signaling	3/37	70/10704	0.00177476026797019	0.00772176397292293	0.00514565765598005	HLA-A/HLA-B/HLA-C	3
R-HSA-202430	Translocation of ZAP-70 to Immunological synapse	2/37	19/10704	0.00191584546175694	0.00819189093992624	0.00545894260428022	HLA-DRA/HLA-DRB1	2
R-HSA-164938	Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters	2/37	21/10704	0.00234258105867432	0.00984678139917343	0.00656173463357483	B2M/HLA-A	2
R-HSA-202427	Phosphorylation of CD3 and TCR zeta chains	2/37	22/10704	0.0025712428140935	0.0106278036315865	0.0070821951195207	HLA-DRA/HLA-DRB1	2
R-HSA-389948	PD-1 signaling	2/37	23/10704	0.0028100083280371	0.0114242961533312	0.00761296475412985	HLA-DRA/HLA-DRB1	2
R-HSA-72766	Translation	5/37	291/10704	0.00306482246077955	0.0122592898431182	0.00816939093959914	RPLP1/RPLP2/RPS17/RPS18/RPS6	5
R-HSA-3000170	Syndecan interactions	2/37	27/10704	0.00386473810186755	0.0152135722105262	0.0101380765579483	COL1A2/COL3A1	2
R-HSA-164952	The role of Nef in HIV-1 replication and disease pathogenesis	2/37	28/10704	0.0041529979010803	0.0160928668666862	0.0107240241853554	B2M/HLA-A	2
R-HSA-3000157	Laminin interactions	2/37	30/10704	0.00475853951751801	0.0178805727324919	0.0119153222368473	COL4A1/COL4A2	2
R-HSA-8874081	MET activates PTK2 signaling	2/37	30/10704	0.00475853951751801	0.0178805727324919	0.0119153222368473	COL1A2/COL3A1	2
R-HSA-202433	Generation of second messenger molecules	2/37	34/10704	0.00608385260500304	0.0225193350155337	0.0150065178159541	HLA-DRA/HLA-DRB1	2
R-HSA-977225	Amyloid fiber formation	3/37	110/10704	0.00636510339734859	0.0232139065079772	0.0154693689378286	B2M/H4C12/LYZ	3
R-HSA-8875878	MET promotes cell motility	2/37	41/10704	0.00875875298023502	0.0311935641687841	0.0207868827440539	COL1A2/COL3A1	2
R-HSA-71291	Metabolism of amino acids and derivatives	5/37	374/10704	0.00880463504764068	0.0311935641687841	0.0207868827440539	RPLP1/RPLP2/RPS17/RPS18/RPS6	5
R-HSA-202733	Cell surface interactions at the vascular wall	3/37	137/10704	0.0116008898914267	0.0405214182123073	0.0270028126457226	CD74/COL1A2/JCHAIN	3
R-HSA-9018519	Estrogen-dependent gene expression	3/37	150/10704	0.01479602022669	0.05096406966971	0.0339616253741276	CTSD/H4C12/TFF1	3
R-HSA-388841	Costimulation by the CD28 family	2/37	69/10704	0.0235887798925486	0.0801372248404391	0.0534021404921432	HLA-DRA/HLA-DRB1	2
R-HSA-2559583	Cellular Senescence	3/37	197/10704	0.030162050878276	0.100258921192185	0.0668109109812098	H1-5/H4C12/IGFBP7	3
R-HSA-6806834	Signaling by MET	2/37	79/10704	0.0303202382637656	0.100258921192185	0.0668109109812098	COL1A2/COL3A1	2
R-HSA-2559586	DNA Damage/Telomere Stress Induced Senescence	2/37	80/10704	0.031030978778292	0.101258983381795	0.0674773361245407	H1-5/H4C12	2
R-HSA-1250342	PI3K events in ERBB4 signaling	1/37	10/10704	0.0340478579302725	0.108254727778302	0.0721391861680538	NRG1	1
R-HSA-1462054	Alpha-defensins	1/37	10/10704	0.0340478579302725	0.108254727778302	0.0721391861680538	DEFA5	1
R-HSA-983169	Class I MHC mediated antigen processing & presentation	4/37	370/10704	0.0378065073456536	0.118683719262305	0.0790888961128262	B2M/HLA-A/HLA-B/HLA-C	4
R-HSA-430116	GP1b-IX-V activation signalling	1/37	12/10704	0.0407207709931835	0.125540412751643	0.083658084898166	COL1A2	1
R-HSA-8939211	ESR-mediated signaling	3/37	223/10704	0.0412442949274383	0.125540412751643	0.083658084898166	CTSD/H4C12/TFF1	3
R-HSA-1358803	Downregulation of ERBB2:ERBB3 signaling	1/37	13/10704	0.0440403867314231	0.125540412751643	0.083658084898166	NRG1	1
R-HSA-140342	Apoptosis induced DNA fragmentation	1/37	13/10704	0.0440403867314231	0.125540412751643	0.083658084898166	H1-5	1
R-HSA-1679131	Trafficking and processing of endosomal TLR	1/37	13/10704	0.0440403867314231	0.125540412751643	0.083658084898166	CTSB	1
R-HSA-2168880	Scavenging of heme from plasma	1/37	13/10704	0.0440403867314231	0.125540412751643	0.083658084898166	JCHAIN	1
R-HSA-75205	Dissolution of Fibrin Clot	1/37	13/10704	0.0440403867314231	0.125540412751643	0.083658084898166	PLAT	1
R-HSA-8847993	ERBB2 Activates PTK6 Signaling	1/37	13/10704	0.0440403867314231	0.125540412751643	0.083658084898166	NRG1	1
R-HSA-202424	Downstream TCR signaling	2/37	98/10704	0.0449082863616852	0.126559716110204	0.0843373320428776	HLA-DRA/HLA-DRB1	2
R-HSA-1250347	SHC1 events in ERBB4 signaling	1/37	14/10704	0.0473488242668204	0.12903855404584	0.0859891892410735	NRG1	1
R-HSA-166786	Creation of C4 and C2 activators	1/37	14/10704	0.0473488242668204	0.12903855404584	0.0859891892410735	C1QB	1
R-HSA-189483	Heme degradation	1/37	14/10704	0.0473488242668204	0.12903855404584	0.0859891892410735	FABP1	1
R-HSA-6785631	ERBB2 Regulates Cell Motility	1/37	15/10704	0.0506461201977961	0.135056320527456	0.0899993307419807	NRG1	1
R-HSA-75892	Platelet Adhesion to exposed collagen	1/37	15/10704	0.0506461201977961	0.135056320527456	0.0899993307419807	COL1A2	1
R-HSA-1963640	GRB2 events in ERBB2 signaling	1/37	16/10704	0.0539323110063541	0.139325136766415	0.0928440003069912	NRG1	1
R-HSA-1963642	PI3K events in ERBB2 signaling	1/37	16/10704	0.0539323110063541	0.139325136766415	0.0928440003069912	NRG1	1
R-HSA-2559584	Formation of Senescence-Associated Heterochromatin Foci (SAHF)	1/37	16/10704	0.0539323110063541	0.139325136766415	0.0928440003069912	H1-5	1
R-HSA-2559582	Senescence-Associated Secretory Phenotype (SASP)	2/37	112/10704	0.0570018893522747	0.145736789271795	0.0971166210342608	H4C12/IGFBP7	2
R-HSA-2022377	Metabolism of Angiotensinogen to Angiotensins	1/37	18/10704	0.0604715226043284	0.153029975570137	0.101976681513207	CTSD	1
R-HSA-202403	TCR signaling	2/37	120/10704	0.0643691551385705	0.16124798458955	0.107453028779964	HLA-DRA/HLA-DRB1	2
R-HSA-1250196	SHC1 events in ERBB2 signaling	1/37	22/10704	0.0734182767014694	0.179930673182865	0.119902867952928	NRG1	1
R-HSA-9665686	Signaling by ERBB2 TMD/JMD mutants	1/37	22/10704	0.0734182767014694	0.179930673182865	0.119902867952928	NRG1	1
R-HSA-162909	Host Interactions of HIV factors	2/37	130/10704	0.074003744615533	0.179930673182865	0.119902867952928	B2M/HLA-A	2
R-HSA-166663	Initial triggering of complement	1/37	23/10704	0.0766277434457165	0.184501751209104	0.122948959846474	C1QB	1
R-HSA-163560	Triglyceride catabolism	1/37	24/10704	0.0798263927756027	0.186763635927825	0.124456242956997	FABP1	1
R-HSA-166208	mTORC1-mediated signalling	1/37	24/10704	0.0798263927756027	0.186763635927825	0.124456242956997	RPS6	1
R-HSA-9620244	Long-term potentiation	1/37	24/10704	0.0798263927756027	0.186763635927825	0.124456242956997	NRG1	1
R-HSA-9664565	Signaling by ERBB2 KD Mutants	1/37	25/10704	0.0830142601414545	0.19200735703297	0.127950573235044	NRG1	1
R-HSA-9006931	Signaling by Nuclear Receptors	3/37	299/10704	0.0836161070950031	0.19200735703297	0.127950573235044	CTSD/H4C12/TFF1	3
R-HSA-1227990	Signaling by ERBB2 in Cancer	1/37	26/10704	0.0861913808807343	0.192571733859659	0.128326664753677	NRG1	1
R-HSA-189445	Metabolism of porphyrins	1/37	26/10704	0.0861913808807343	0.192571733859659	0.128326664753677	FABP1	1
R-HSA-6803529	FGFR2 alternative splicing	1/37	26/10704	0.0861913808807343	0.192571733859659	0.128326664753677	PTBP1	1
R-HSA-9635486	Infection with Mycobacterium tuberculosis	1/37	27/10704	0.0893577902183829	0.197863678340705	0.131853130303441	B2M	1
R-HSA-8863795	Downregulation of ERBB2 signaling	1/37	29/10704	0.0956586150280478	0.209941031211999	0.139901281410373	NRG1	1
R-HSA-2424491	DAP12 signaling	1/37	30/10704	0.0987931003904799	0.214918323656483	0.143218067971425	B2M	1
R-HSA-1251985	Nuclear signaling by ERBB4	1/37	32/10704	0.105030390922561	0.22650032129387	0.150936122424183	NRG1	1
R-HSA-114604	GPVI-mediated activation cascade	1/37	35/10704	0.114307644597227	0.244381860863036	0.162852088945232	COL1A2	1
R-HSA-8979227	Triglyceride metabolism	1/37	37/10704	0.120440426234709	0.255292527403486	0.17012277929689	FABP1	1
R-HSA-76009	Platelet Aggregation (Plug Formation)	1/37	39/10704	0.126531882744669	0.265931414582017	0.177212360311446	COL1A2	1
R-HSA-165159	MTOR signalling	1/37	41/10704	0.132582284907853	0.276305938295357	0.184125773821609	RPS6	1
